Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Tonalin CLA reduces body fat

Aug. 5, 1997

Rezulin receives FDA marketing clearance for type 2 diabetes

Aug. 5, 1997

Sibutramine: New hope for obese patients

Aug. 5, 1997

Bioniche to manufacture Orphan Medical's Intrachol

Aug. 5, 1997

U.S. patent issues for bone substitute technology

Aug. 5, 1997

Insulin mediator isolated from beef liver

Aug. 5, 1997

Alteon's pimagedine progresses to phase III

Aug. 4, 1997

Crinone approved in U.S. for additional indication

Aug. 4, 1997

Ergoset improves metabolism in healthy obese women

Aug. 4, 1997

Novartis reports new NPY antagonists with selectivity for Y5 receptors

Aug. 1, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
SKL-35501 shows broad antitumor activity in solid tumors
BioWorld Science
Neurotensin receptor 1 (NTSR1) is overexpressed in several aggressive solid tumors, including colorectal and pancreatic cancer, making it a promising therapeutic...